As Hca Healthcare INC (HCA) Share Value Declined, Shareholder Consulta LTD Has Cut Position

HCA Healthcare, Inc. (NYSE:HCA) LogoInvestors sentiment increased to 1.08 in Q4 2018. Its up 0.26, from 0.82 in 2018Q3. It improved, as 37 investors sold HCA shares while 200 reduced holdings. 77 funds opened positions while 178 raised stakes. 247.43 million shares or 5.65% more from 234.20 million shares in 2018Q3 were reported. Element Capital Llc reported 0.09% of its portfolio in HCA Healthcare, Inc. (NYSE:HCA). Pnc Finance Svcs Inc has 99,821 shares for 0.01% of their portfolio. 28 are held by Community Bankshares Na. Alyeska Invest Gru LP reported 0.14% stake. Amer has invested 0.06% in HCA Healthcare, Inc. (NYSE:HCA). Cornerstone Advsr invested in 32,000 shares. Loring Wolcott & Coolidge Fiduciary Llp Ma invested in 1,034 shares. Jane Street Gp Limited Liability Corporation, a New York-based fund reported 4,145 shares. Tiaa Cref Investment Mngmt Limited Co accumulated 2.12 million shares. Hbk Ltd Partnership has 0.27% invested in HCA Healthcare, Inc. (NYSE:HCA). Dupont Cap Mgmt, a Delaware-based fund reported 36,301 shares. Lombard Odier Asset Management (Europe) Ltd reported 2,952 shares. Utd Advisers Limited Liability reported 7,606 shares stake. Amf Pensionsforsakring stated it has 203,496 shares or 0.28% of all its holdings. Royal Savings Bank Of Canada reported 0.04% stake.

Since October 31, 2018, it had 0 insider buys, and 18 insider sales for $30.48 million activity. Cuffe Michael S. sold $709,358 worth of stock. $4.72 million worth of HCA Healthcare, Inc. (NYSE:HCA) shares were sold by STEELE JOHN M. Englebright Jane D. sold 5,081 shares worth $720,994. Whalen Kathleen M sold $27,896 worth of HCA Healthcare, Inc. (NYSE:HCA) on Wednesday, February 6. Reiner Deborah M also sold $72,639 worth of HCA Healthcare, Inc. (NYSE:HCA) on Tuesday, January 29. The insider Torres Kathryn A. sold 820 shares worth $116,732.

Consulta Ltd decreased its stake in Hca Healthcare Inc (HCA) by 13.33% based on its latest 2018Q4 regulatory filing with the SEC. Consulta Ltd sold 100,000 shares as the company’s stock declined 5.73% while stock markets rallied. The institutional investor held 650,000 shares of the health care company at the end of 2018Q4, valued at $80.89 million, down from 750,000 at the end of the previous reported quarter. Consulta Ltd who had been investing in Hca Healthcare Inc for a number of months, seems to be less bullish one the $45.35 billion market cap company. The stock increased 0.44% or $0.58 during the last trading session, reaching $132.35. About 2.92 million shares traded or 66.56% up from the average. HCA Healthcare, Inc. (NYSE:HCA) has risen 36.88% since March 17, 2018 and is uptrending. It has outperformed by 32.51% the S&P500.

Analysts await HCA Healthcare, Inc. (NYSE:HCA) to report earnings on May, 7. They expect $2.31 EPS, down 0.86 % or $0.02 from last year’s $2.33 per share. HCA’s profit will be $791.51M for 14.32 P/E if the $2.31 EPS becomes a reality. After $2.99 actual EPS reported by HCA Healthcare, Inc. for the previous quarter, Wall Street now forecasts -22.74 % negative EPS growth.

More notable recent HCA Healthcare, Inc. (NYSE:HCA) news were published by: which released: “HCA Healthcare Announces Greg Lowe as President of Newly Created North Carolina Division – Business Wire” on February 20, 2019, also with their article: “HCA Healthcare Appoints Meg Crofton as New Independent Director – Business Wire” published on February 21, 2019, published: “Analysis: Positioning to Benefit within Fiserv, Align Technology, The Boeing, RE/MAX, HCA Healthcare, and CoreLogic — Research Highlights Growth, Revenue, and Consolidated Results – GlobeNewswire” on March 06, 2019. More interesting news about HCA Healthcare, Inc. (NYSE:HCA) were released by: and their article: “HCA Healthcare Named a World’s Most Ethical Company for 10th Consecutive Year – Business Wire” published on February 26, 2019 as well as‘s news article titled: “HCA board member steps down, will be replaced by former Disney exec – Nashville Business Journal” with publication date: February 26, 2019.

HCA Healthcare, Inc. (NYSE:HCA) Ratings Coverage

Among 8 analysts covering HCA Healthcare (NYSE:HCA), 7 have Buy rating, 1 Sell and 0 Hold. Therefore 88% are positive. HCA Healthcare had 10 analyst reports since September 18, 2018 according to SRatingsIntel. On Wednesday, October 31 the stock rating was maintained by Jefferies with “Buy”. The rating was maintained by Bank of America with “Underperform” on Tuesday, September 18. The firm has “Buy” rating given on Tuesday, November 6 by Argus Research. Citigroup maintained HCA Healthcare, Inc. (NYSE:HCA) on Thursday, October 11 with “Buy” rating. The stock of HCA Healthcare, Inc. (NYSE:HCA) has “Outperform” rating given on Thursday, November 1 by Credit Suisse.

HCA Healthcare, Inc. (NYSE:HCA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.